All Companies
Ticker SNSE
This stock is no longer actively trading
You reached the page — here's exactly what SNSE is, and why it's out of scope for now.
What this ticker is
SNSE
Sensei Biotherapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $18.6M
Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its proprietary ImmunoPhage platform. This immunotherapy leverages bacteriophages to orchestrate a precise and robust innate and adaptive immune response. They als…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted